Phathom Pharmaceuticals, Inc. PHAT Total Cost of Revenue
Total Cost of Revenue at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s total cost of revenue?
- Phathom Pharmaceuticals, Inc. (PHAT) reported total cost of revenue of $12M in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s total cost of revenue changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s total cost of revenue increased by 222.1% year-over-year, from $3.72M to $12M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.